Webster Santos, professor of chemistry and the Cliff and Agnes Lilly Faculty Fellow in the College of Science at Virginia Tech, recently received a $2.8 million award from the National Institute of Allergy and Infectious Diseases to discover drugs to inhibit a small molecule transporter.
The grant awarded to Esther Wisdom, a junior in the Honors College, is one of 17 of the approved proposals submitted by undergraduate students. Overall, 12 percent of the grant applications were approved for funding.
Researchers, including Carla Finkielstein, are now discovering that molecules usually implicated in protecting us from cancer initiation and progression are directly involved in regulating the function of our daily circadian rhythms.
Researchers have developed a process to chemically attach nanoparticles of anti-cancer drugs onto attenuated bacteria cells, which they have shown to be more effective than the passive delivery of injections at reaching cancer sites.
In her role as an assistant professor in VTCSOM's Department of Basic Science Education, the three-time Hokie, veterinary pathologist, and researcher will teach medical students as well as conduct translational research in inflammatory bowel disease and colorectal cancer.
People more recently diagnosed with cancer are more likely to drink alcohol, use tobacco, and frequent tanning beds than people in later stages of recovery, according to a research team from the Virginia Tech Carilion Research Institute and Roswell Park Comprehensive Cancer Center.
Silke Hauf, an associate professor of biological sciences in the College of Science at Virginia Tech, studies a cellular surveillance pathway, or a cellular "checkpoint," that prevents cells from acquiring the wrong number of chromosomes.
Scientists with the Virginia Tech Carilion Research Institute say a gene involved in the body’s sleep cycle is a potential target for therapies to help patients with a deadly form of brain cancer known as glioblastoma.
Deb Kelly, who is also an associate professor of biological sciences in the College of Science at Virginia Tech, is working to better detect, prevent, and repair the mutations found in cancers related to the breast cancer susceptibility protein, BRCA1.
Scientists at the Virginia Tech Carilion Research Institute have added a new dimension to the understanding of how cells alter their communication with one another during development, wound healing, and the spread of cancer.
The program is based on the Virginia Tech Carilion Health Sciences and Technology Campus in Roanoke, and it positions students to conduct research in more than 50 departments and institutes across Virginia Tech.
The National Cancer Institute of the National Institutes of Health has awarded Deborah Kelly, an associate professor at the Virginia Tech Carilion Research Institute, $2 million to study the mutated form of the breast cancer susceptibility protein that is implicated in hereditary breast cancer.
Known as the silent killer, ovarian cancer is notorious for avoiding detection until it has progressed to an advanced stage. New research from Virginia Tech on fluid shear stress in the abdominal cavity is moving physicians closer to earlier diagnosis and more effective treatment.
A major advancement has been made on how epigenomics are studied that permits mapping a genome-scale profile of epigenetic changes using less than a couple hundred cells, a factor of 100-300 reduction in the sample amount compared to existing alternatives.
A relatively unexplored area of cancer research, interstitial fluid flow, or the movement of fluid around and through the three-dimensional space surrounding cells, has been shown to lead to an increase in cancer cell invasion. However, the mechanisms of how and why that happens, particularly in cases of brain cancer, are still unknown.
Acomhal Research Inc., formed to fight a deadly type of brain cancer, is being recognized this week by the Association of Public and Land-Grant Universities and the Association of American Universities.
The 139,000-gross-square-foot building will rise on the Virginia Tech Carilion Health Sciences and Technology Campus at Jefferson Street and Reserve Avenue and will be physically connected by an elevated walkway to the Virginia Tech Carilion School of Medicine and Research Institute. It is expected to open in 2020.